Clinical Trials

Showing 281 - 300 of 449 trials
Title Investigatorsort icon Disease(s)
Prostate Cancer Treatment Decision-Making and Survivorship
[Protocol 11-058]
Nelson, Christian
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
  • Survivorship
A Phase I/II Study of EPOCH Chemotherapy, Bortezomib, and Raltegravir for the Treatment of HTLV-1-Associated T-Cell Leukemia/Lymphoma
[Protocol 12-146]
Noy, Ariela
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin's Lymphoma
[Protocol 11-013]
Noy, Ariela
  • AIDS-Associated Cancers
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Dose-Adjusted EPOCH Chemotherapy with or without Rituximab in Patients with Untreated Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, or Plasmablastic Lymphoma
[Protocol 13-022]
Noy, Ariela
  • Lymphoma
    • Non-Hodgkin's Lymphoma
High-Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B-Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients
[Protocol 10-181]
Noy, Ariela
  • AIDS-Associated Cancers
    • AIDS-Associated Lymphomas
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Study of Bortezomib plus (R)ICE in Subjects with Relapsed/Refractory AIDS-Associated Non-Hodgkin's Lymphoma
[Protocol 09-063]
Noy, Ariela
  • AIDS-Associated Cancers
    • AIDS-Associated Lymphomas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234]
O'Reilly, Eileen
  • Upper Gastrointestinal
    • Pancreatic Cancer
Two Phase II Studies of Veliparib for Pancreatic Cancer with a BRCA or PALB2 Mutation: Gemcitabine & Cisplatin with/without Veliparib in Untreated Pancreatic Cancer (Part I) & Veliparib Alone for Patients with Previously Treated Pancreatic Cancer (Part II
[Protocol 12-045]
O'Reilly, Eileen
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I/II Study of M402 in Combination with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-078]
O'Reilly, Eileen
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055]
O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Blood and Marrow Transplantation
    • Transplantation
  • Leukemia
  • Lymphoma
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation
[Protocol 12-086]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders
[Protocol 10-150]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Hematologic Disorders
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLA-Compatible Donor
[Protocol 12-053]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
  • Hematology
    • Hematologic Disorders
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
[Protocol 10-104]
Oeffinger, Kevin
  • Breast Cancer
  • Survivorship
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051]
Offit, Kenneth
  • Breast Cancer
  • Colorectal Cancer
    • Colon Cancer
  • Hereditary Cancer & Genetics
  • Ovarian Cancer
  • Prostate Cancer